Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04095091 · ClinicalTrials.gov registry record

Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)

A clinical trial, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
30
Enrollment target

NCT04095091: Clinical Trial study, sponsored by University of Wisconsin, Madison.

NCT04095091 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04095091 was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
30 participants
Enrollment target

Study Summary

The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. The secondary objective of this study is to determine if several salient features identified in the US scan can be used to predict target motion identified in the MR scan.

Primary Outcome

To conduct non-contrast agent MR and ultrasound scans in order to evaluate and demonstrate, on a continuing basis, the technical and clinical feasibility of new or modified features (the "Prototype") of a combined MRI and ultrasound system, and software. Prototype MRI and ultrasound systems are defined as components of the MRI system (software) and ultrasound system (hardware and software) that have been modified in some form.

Interventions

  • DEVICE 4D Planar US Transducer

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-09-14
Est. Completion 2019-10-04
University of Wisconsin, Madison

1,039 total trials

Why NCT04095091 stopped before completion

NCT04095091 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which 4D Planar US Transducer is the first listed.

NCT04095091 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04095091 about?

NCT04095091 is a clinical study titled "Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR)". The primary objective of this protocol is to evaluate the feasibility of acquiring simultaneous 4D ultrasound and 4D MRI scans. The imaging performance of the US and MRI scans will be characterized. The secondary objective of this study is to determine if several salient features identified in the U...

What is the current status of trial NCT04095091?

This trial is currently terminated. The enrollment target is 30 participants. The study started on 2017-09-14. Estimated completion is 2019-10-04.

What interventions are being tested in trial NCT04095091?

The interventions under investigation include: 4D Planar US Transducer (DEVICE).

Who is sponsoring clinical trial NCT04095091?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04095091, the US trial registry maintained by the National Library of Medicine. NCT04095091 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.